Watson Gets License From Teva As Part Of Settlement

Law360, New York (May 7, 2010, 6:09 PM EDT) -- Watson Pharmaceuticals Inc. said Friday that it had reached a settlement with Teva Pharmaceutical Industries Ltd. in a patent infringement dispute over the oral contraceptive Seasonale.

Under the settlement agreement, Teva subsidiary Teva Women's Health Inc. will grant Watson subsidiary Watson Laboratories Inc. a fully paid-up license to the U.S. patents covering Seasonale tablets, and Watson will continue marketing its generic equivalent product known as Quasense, according to Watson.

Morristown, N.J.-based Watson admitted that the licensed patents were valid and enforceable, but the remaining terms of...
To view the full article, register now.